- NRx Pharmaceuticals (NRXP) said Tuesday it plans to launch an underwritten public offering of common stock, with the underwriter granted a 30-day option to purchase up to an additional 15% of shares sold.
- The clinical-stage biopharmaceutical company said it intends
